← Open Payments lookup

JENNIFER WALK: Open Payments

NPI 1346619095 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$228 in 14 payments from 10 companies in 2025. Trend: 2023 $57 · 2024 $316 · 2025 $228

Food & beverage: $228
CompanyPaymentsAmount
GlaxoSmithKline, LLC.2$34
Otsuka America Pharmaceutical, Inc.2$31
Exact Sciences Corporation2$30
ABBVIE INC.2$30
Dexcom, Inc.1$22
Novo Nordisk Inc1$19
Amphastar Pharmaceuticals, Inc.1$17
AstraZeneca Pharmaceuticals LP1$17
Boehringer Ingelheim Pharmaceuticals, Inc.1$14
Sumitomo Pharma America, Inc.1$14

Products named: SHINGRIX, REXULTI, The Cologuard Plus Collection Kit, VRAYLAR, Dexcom G6 Transmitter, Rybelsus, BREZTRI, JARDIANCE.

Industry payments across MO — which companies pay providers there.